May 6, 2016

New Clinical Trials

new clinical trials

A Phase II Trial of a Novel Proteasome/IMiD Combination, Ixazomib, Pomalidomide, and Dexamethasone, in Relapsed Multiple Myeloma Patients UARK 2015-03 Principal Investigator: Faith Davies, M.D. Identifier: NCT02578121 The primary objective is to determine the efficacy of ixazomib when combined with pomalidomide and dexamethasone, in terms of overall response rate in patients with relapsed myeloma….

Advancing Cure with CyTOF Technology


[fullwidth background_color=”” background_image=”” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_repeat=”no-repeat” background_position=”left top” video_url=”” video_aspect_ratio=”16:9″ video_webm=”” video_mp4=”” video_ogv=”” video_preview_image=”” overlay_color=”” overlay_opacity=”0.5″ video_mute=”yes” video_loop=”yes” fade=”no” border_size=”0px” border_color=”” border_style=”” padding_top=”20″ padding_bottom=”20″ padding_left=”” padding_right=”” hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”no” menu_anchor=”” class=”” id=””][one_half last=”no” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” hover_type=”none” link=”” border_position=”all” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ animation_offset=””…

Immune Cells of the Bone Marrow — A Brief Primer

Bone marrow is the spongy tissue inside our bones that produces blood cells — red blood cells, platelets, and white blood cells. White blood cells help the body fight against infection. There are many different types of white blood cells, including lymphocytes, neutrophils, and monocytes. They fight against invading bacteria, viruses or fungi to help…



Monoclonal Antibody Therapy in Multiple Myeloma: Where Do We Stand and Where Are We Going? A new publication in the journal Immunotherapy (monthly peer-reviewed journal covering immunology and immunotherapy) 2016 Mar; 8 (3): 367-84 Primary Author: Sharmilan Thanendrarajan, M.D., Assistant Professor Abstract Multiple myeloma is a plasma cell malignancy that is characterized by refractory and relapsing course…

Walker brings Molecular Genetics Expertise to the Myeloma Institute

Brian Walker

Aspecialist in molecular immunology and molecular genetics, Brian Walker, Ph.D., left his native United Kingdom (UK) in October 2015 to join the Myeloma Institute as professor of medicine and director of research. As a high school student in Scotland, Walker expected he would pursue a career in mathematics until “a good biology teacher changed all…

Research Grant Awarded To Dr. Schinke

Carolina Schinke

Carolina Schinke, M.D., assistant professor at the Myeloma Institute, has been awarded a 2016 UAMS Medical Research Endowment Fund grant. Grants from the Medical Research Endowment Fund provide pilot research funding that has the potential to develop into extramurally funded, scientifically significant research projects. Support is focused on new areas of research for young faculty investigators…

Fighting Back to Good Health

The ability to get up after being knocked down and rise to new heights is an attribute that can help shape our lives and help us cope with life’s challenges. Chuck Cordell knows first-hand the value of this attribute. When struck with adversity, he faced it head on, drew from his inner core to fight…

Supporting the Whole Patient

Harold Dean counsels a patient after treatment.

A diagnosis of a cancer like myeloma can be devastating. Fear of the unknown, uncertainty about the future, and concerns about how everyone — patient and loved ones — will be affected can be overwhelming.  While doctors and nurses can offer encouragement and information about what to expect, social workers can provide solace and help…

behind the scenes

behind the scenes

Tarun Garg, Ph.D. Dr. Garg earned a Ph.D. in Zoology from Banaras Hindu University in India and completed post-doctoral fellowships in Neurobiology and Developmental Sciences and Multiple Myeloma at the University of Arkansas for Medical Sciences. Dr. Garg’s research is focused on developing highly activated expanded natural killer (ENK) cell therapy for high-risk relapsed multiple…

March 15, 2016

Myeloma Awareness Month Upcoming Activities

St. Patrick’s Day Bake Sale to benefit Patient Support Sponsored by Myeloma Institute Social Work Dept. Thursday, March 17th Myeloma Institute Clinic and F7 Inpatient Unit Fighting for a Cure with Captain America Yoga, refreshments, and more! Sponsored by Infusion 4 Tuesday, March 29th Cancer Institute 4th Floor, Infusion 4 MARCHing for a Cure Entertainment…

Next page